drugset / Trial / NCT02814461
The Safety and Maximum Tolerated Dose of Axitinib in Combination With Radiotherapy for HCC
NaSingle-groupOpen-labelTreatment
Summary
To determine the maximal tolerated dose (MTD) of axitinib in combination with RT for advanced HCC.
Timeline
- Start
- 2015-11
- Primary completion
- 2018-11
- Completion
- 2018-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Axitinib | Small molecule | 1 mg | — |
| Subject | Axitinib | Small molecule | 2 mg | — |
| Subject | Axitinib | Small molecule | 3 mg | — |